Massachusetts drug compounder recalls injectable drugs

Mar. 26, 2013

Written by

Walter F. Roche Jr.

The Tennessean

Another Massachusetts drug compounding firm is recalling more than a dozen of its products after an inspection found foreign material in vials of drugs.

Pallimed Solutions Inc. of Woburn announced what it called a voluntary recall Monday of injectable sterile drugs, including atropine and testosterone cypionate, produced after Jan. 1, 2013. According to its website, the company provides drugs for treatment of ailments ranging from nail fungus to sexual dysfunction.

The recall followed an inspection by state and federal regulators who have been focusing on compounding pharmacies, particularly those producing injectable drugs that are supposed to be sterile. Regulators stepped up inspections in the wake of a nationwide fungal meningitis outbreak that has been blamed on another now-closed Massachusetts compounding firm.

The recall came after the Massachusetts Board of Pharmacy on Friday issued a cease-and-desist order barring Pallimed from producing any sterile compounded drugs. It will continue to produce non-sterile products.

Pallimed was cited by state regulators late last year for producing a Viagra substitute with incorrect components. The company was ordered to stop production. Pallimed does not have a Tennessee license, according to state health officials. A company spokeswoman declined to say whether the firm had any Tennessee customers, stating that the FDA would later release that information.